Gastrointestinal Surgery Unit III

Song Xinming

Chief physician, Professor

Overview

Clinical Interests：

*Be skilled in minimally invasive surgical treatment for colorectal cancer, especially for anus function and sexual function protection in ultra-low rectal cancer;

*Be skilled in normalize radical operation and minimally invasive surgical treatment for gastric cancer and gastrointestinal stromal tumors;

*The surgical treatment for inflammatory bowel diseases.

Medical Education：

September 1994 - June 1997, The First Affiliated Hospital of Sun Yat-Sen University, Doctor Degree

Work Experiences：

August 1988 - September 1994: Guangzhou General Hospital of Guangzhou Military Command, Doctor, Attending doctor

January 1998 - November 2003: Guangzhou General Hospital of Guangzhou Military Command, Associate Consultant

December 2003 - Now: The First Affiliated Hospital of Sun Yat-Sen University, Consultant and Professor

Biography

Membership of Professional Organizations:

1. Deputy director of the committee of Association of Gastrointestinal Diseases, Guangdong Health Management Association

2. Deputy director of the committee of Association of Colorectal and Anal Surgical Management, Guangdong Medical Industry Association

3. Membership of standing committee of Association of Gastroenterological Surgery, Guangdong Medical Association

4. Membership of standing committee of Association of Colorectal Cancer, Guangdong Anti- Cancer Association

Articles( The number of articles had published  about 100, including 20 SCI  articles):

1. Qin CJ, Song XM*, Chen ZH, Ren XQ, Xu KW, Jing H, He YL. XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy. Oncotarget. 2015; 6(31):32193-32204.

2. Song XM*, Gao X, Li MZ, Chen ZH, et al. Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: analysis of a South china cohort. Dis Colon Rectum. 2011; 54(9):1147-54.

3. Xu K, Song X*, Chen Z, Qin C, He Y, Zhan W. XRCC2 Promotes Colorectal Cancer Cell Growth, Regulates Cell Cycle Progression, and Apoptosis. Medicine (Baltimore). 2014; 93(28):e294.

4.  Qin CJ, Xu KW, Chen ZH, Zhai ET, He YL, Song XM*. XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis. Tumour Biol. 2015; 36(2):461-6.

Monographs or Translations:

1.《Surgery of Gastric cancer》

2.《Operative Gastrointestinal Surgery》